Amedeo Smart

Free Medical Literature Service

 

Amedeo

Tuberculosis
  Free Subscription

Articles published in
J Infect
    April 2024
  1. LIANG Q, Jiang X, Jia J, Zhao L, et al
    An early and trustable indicator suggestive of non-tuberculosis mycobacteria isolation in a high Tuberculosis burden setting.
    J Infect. 2024 Apr 2:106149. doi: 10.1016/j.jinf.2024.106149.
    >> Share

    February 2024
  2. BUREL JG, Wang W, Wuhrer M, Dedicoat M, et al
    IgG glycosylation associates with risk of progression from latent to active tuberculosis.
    J Infect. 2024 Feb 1:S0163-4453(24)00033-1. doi: 10.1016/j.jinf.2024.
    >> Share

    December 2023
  3. LONG R, Croxen M, Lee R, Doroshenko A, et al
    The Association between PHYLOGENETIC LINEAGE AND THE SUBCLINICAL Phenotype OF PULMONARY TUBERCULOSIS: A retrospective 2-Cohort study.
    J Infect. 2023 Dec 15:S0163-4453(23)00592-3. doi: 10.1016/j.jinf.2023.
    >> Share

  4. LIU Y, Sun R, Zhang H, Huang J, et al
    Trends and predictions of tuberculosis notification in mainland China during and after the COVID-19 pandemic.
    J Infect. 2023;87:e100-e103.
    >> Share

    November 2023
  5. HUANG Z, Huang H, Hu J, Xia L, et al
    A novel quantitative urine LAM strip for point-of-care tuberculosis diagnosis in non-HIV adults.
    J Infect. 2023 Nov 28:S0163-4453(23)00586-8. doi: 10.1016/j.jinf.2023.
    >> Share

    October 2023
  6. ZHANG G, Zhang H, Zhang Y, Hu X, et al
    Targeted Next-Generation Sequencing Technology Showed Great Potential in Identifying Spinal Tuberculosis and Predicting the Drug Resistance.
    J Infect. 2023 Oct 26:S0163-4453(23)00549-2. doi: 10.1016/j.jinf.2023.
    >> Share

  7. CHESOV E, Chesov D, Reimann M, Dreyer V, et al
    Impact of Mycobacterium tuberculosis strain type on multidrug-resistant tuberculosis severity, Republic of Moldova.
    J Infect. 2023 Oct 10:S0163-4453(23)00532-7. doi: 10.1016/j.jinf.2023.
    >> Share

    September 2023
  8. WANG L, Ma H, Wen Z, Niu L, et al
    Single-cell RNA-sequencing reveals heterogeneity and intercellular crosstalk in human tuberculosis lung.
    J Infect. 2023 Sep 8:S0163-4453(23)00506-6. doi: 10.1016/j.jinf.2023.
    >> Share

    June 2023
  9. PEDERSEN OS, Holmgaard FB, Mikkelsen MKD, Lange C, et al
    Global treatment outcomes of extensively drug-resistant tuberculosis in adults: A systematic review and meta-analysis.
    J Infect. 2023 Jun 23:S0163-4453(23)00337-7. doi: 10.1016/j.jinf.2023.
    >> Share

    April 2023
  10. MORRISON H, Perrin F, Dedicoat M, Ahmed R, et al
    Impact of COVID-19 on NHS Tuberculosis Services: Results of a UK-wide survey.
    J Infect. 2023 Apr 10:S0163-4453(23)00204-9. doi: 10.1016/j.jinf.2023.
    >> Share

    March 2023
  11. WANG Y, Sun Q, Zhang Y, Li X, et al
    Systemic immune dysregulation in severe tuberculosis patients revealed by a single-cell transcriptome atlas.
    J Infect. 2023 Mar 30:S0163-4453(23)00191-3. doi: 10.1016/j.jinf.2023.
    >> Share

  12. NAMGUNG SH, Jung J, Kim SK, Kim EO, et al
    Incidence of tuberculosis infection in healthcare workers in high-risk departments for tuberculosis after universal wearing of KF94 mask during COVID-19 pandemic.
    J Infect. 2023 Mar 21:S0163-4453(23)00146-9. doi: 10.1016/j.jinf.2023.
    >> Share

  13. CLARKE J, Moore M, O'Shea MK, Dedicoat M, et al
    Identifying opportunities to improve the microbiological diagnosis of Tuberculosis in a low endemic urban setting.
    J Infect. 2023 Mar 9:S0163-4453(23)00137-8. doi: 10.1016/j.jinf.2023.
    >> Share

    February 2023
  14. BIRD PW, Pan D, Martin CA, Gogoi M, et al
    Awareness of HIV, Hepatitis B, Hepatitis C, Tuberculosis and COVID-19 in Migrant Students in the UK - A Pilot Survey from an Institute of Higher Education.
    J Infect. 2023 Feb 14:S0163-4453(23)00086-5. doi: 10.1016/j.jinf.2023.
    >> Share

  15. KOEHLER N, Andres S, Merker M, Dreyer V, et al
    Pretomanid-Resistant Tuberculosis.
    J Infect. 2023 Feb 2:S0163-4453(23)00069-5. doi: 10.1016/j.jinf.2023.
    >> Share

    January 2023
  16. NORDHOLM AC, Andersen AB, Wejse C, Norman A, et al
    Mental illness, substance abuse, and tuberculosis risk.
    J Infect. 2023 Jan 27:S0163-4453(23)00056-7. doi: 10.1016/j.jinf.2023.
    >> Share

  17. WU X, Liang R, Xiao Y, Liu H, et al
    Application of Targeted Next Generation Sequencing Technology in the Diagnosis of Mycobacterium Tuberculosis and First Line Drugs Resistance Directly from Cell-free DNA of Bronchoalveolar Lavage Fluid.
    J Infect. 2023 Jan 24:S0163-4453(23)00036-1. doi: 10.1016/j.jinf.2023.
    >> Share

  18. ZHAN H, Yang L, Liu Y, Li H, et al
    Acceptance, safety and immunogenicity of a booster dose of inactivated SARS-CoV-2 vaccine in adults with tuberculosis.
    J Infect. 2023 Jan 21:S0163-4453(23)00034-8. doi: 10.1016/j.jinf.2023.
    >> Share

    December 2022
  19. KAUR K, Sharma S, Abhishek S, Kaur P, et al
    Metabolic switching and cell wall remodelling of Mycobacterium tuberculosis during bone tuberculosis.
    J Infect. 2022 Dec 19:S0163-4453(22)00704-6. doi: 10.1016/j.jinf.2022.
    >> Share

  20. LI X, Peng K, Cheng FW, Lam DC, et al
    Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac).
    J Infect. 2022 Dec 17:S0163-4453(22)00706-X. doi: 10.1016/j.jinf.2022.
    >> Share

  21. XU J, Wang Y, Liu F, Yang H, et al
    Changes of tuberculosis infection in mainland China before and after the COVID-19 pandemic.
    J Infect. 2022 Dec 11:S0163-4453(22)00699-5. doi: 10.1016/j.jinf.2022.
    >> Share

    November 2022
  22. CALDERWOOD CJ, Reeve BW, Mann T, Palmer Z, et al
    Clinical utility of C-reactive protein-based triage for presumptive pulmonary tuberculosis in South African adults.
    J Infect. 2022 Nov 11. pii: S0163-4453(22)00639.
    >> Share

  23. HU S, You Y, Zhang S, Tang J, et al
    Multidrug-resistant infection in COVID-19 patients: a meta-analysis.
    J Infect. 2022 Nov 5. pii: S0163-4453(22)00640.
    >> Share

    September 2022
  24. ZHOU Y, Anthony R, Wang S, Ou X, et al
    Corrigendum to 'The epidemic of multidrug resistant tuberculosis in China in historical and phylogenetic perspectives' [Journal of Infection, Volume 80, Issue 4 (2020) Pages 444-453].
    J Infect. 2022 Sep 29. pii: S0163-4453(22)00543.
    >> Share

    August 2022
  25. CHEN YC, Hsiao CC, Wu CC, Chao TY, et al
    Next generation sequencing reveals miR-431-3p/miR-1303 as immune-regulating microRNAs for active tuberculosis.
    J Infect. 2022 Aug 31. pii: S0163-4453(22)00517.
    >> Share

  26. XU Y, Tan Y, Zhang X, Cheng M, et al
    Comprehensive identification of immuno-related transcriptional signature for active pulmonary tuberculosis by integrated analysis of array and single cell RNA-seq.
    J Infect. 2022 Aug 22. pii: S0163-4453(22)00501.
    >> Share

  27. LEE DG, Kim HJ, Park MJ, Hong JH, et al
    Proteomic analysis of sequential isolates of multidrug-resistant Mycobacterium tuberculosis during treatment failure: Altered protein expression in failed MDR-TB treatment.
    J Infect. 2022 Aug 17. pii: S0163-4453(22)00473.
    >> Share

    July 2022
  28. YAN Y, Davgadorj C, Lyu C, Zhang S, et al
    Immunogenicity of a third dose of inactivated COVID-19 vaccine in people living with HIV-1, HBV, and tuberculosis during the Omicron variant epidemic: a cross-sectional study.
    J Infect. 2022 Jul 5. pii: S0163-4453(22)00407.
    >> Share

  29. DHANA A, Hamada Y, Kengne AP, Kerkhoff AD, et al
    Diagnostic accuracy of WHO screening criteria to guide lateral-flow lipoarabinomannan testing among HIV-positive inpatients: A systematic review and individual participant data meta-analysis.
    J Infect. 2022;85:40-48.
    >> Share

    June 2022
  30. TUNESI S, Du DL, Gualano G, Millet JP, et al
    Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study.
    J Infect. 2022;84:834-872.
    >> Share

    May 2022
  31. BACHIR M, Guglielmetti L, Tunesi S, Billard-Pomares T, et al
    Molecular detection of isoniazid monoresistance improves tuberculosis treatment: a retrospective cohort in France.
    J Infect. 2022 May 20. pii: S0163-4453(22)00306.
    >> Share

  32. WYLLIE D, Do T, Myers R, Nikolayevskyy V, et al
    M. tuberculosis microvariation is common and is associated with transmission: analysis of three years prospective universal sequencing in England.
    J Infect. 2022 May 17. pii: S0163-4453(22)00294.
    >> Share

  33. CHEN Y, Liu Q, Takiff HE, Gao Q, et al
    Comprehensive genomic analysis of Mycobacterium tuberculosis reveals limited impact of high-fitness genotypes on MDR-TB transmission.
    J Infect. 2022 May 16. pii: S0163-4453(22)00293.
    >> Share

    April 2022
  34. LIU Q, Chen X, Liu X, Yang D, et al
    Cervical lymph node dissection on the treatment of cervical tuberculosis.
    J Infect. 2022 Apr 25. pii: S0163-4453(22)00242.
    >> Share

    January 2022
  35. LUO Y, Xue Y, Song H, Tang G, et al
    Machine learning based on routine laboratory indicators promoting the discrimination between active tuberculosis and latent tuberculosis infection.
    J Infect. 2022 Jan 4. pii: S0163-4453(21)00666.
    >> Share

  36. LUCEY O, Potter J, Ricketts W, Castle L, et al
    Utility of EBUS-TBNA in diagnosing mediastinal tuberculous lymphadenitis in East London.
    J Infect. 2022;84:17-23.
    >> Share

    October 2021
  37. MONICA R, Lin NW, Laura D, Fidelma F, et al
    Latent tuberculosis infection amongst patients with rheumatic diseases in an Irish Tertiary Referral Centre - A five-year review.
    J Infect. 2021 Oct 27. pii: S0163-4453(21)00510.
    >> Share

    August 2021
  38. DAI Y, Xie L, Wang X, Zhang H, et al
    Depression increases the risk of tuberculosis: preliminary observations.
    J Infect. 2021 Aug 6. pii: S0163-4453(21)00369.
    >> Share

    July 2021
  39. CHENDI BH, Tveiten H, Snyders CI, Tonby K, et al
    CCL1 and IL-2Ra differentiate Tuberculosis disease from latent infection Irrespective of HIV infection in low TB burden countries.
    J Infect. 2021 Jul 29. pii: S0163-4453(21)00379.
    >> Share

  40. RAJAMANICKAM A, Kumar NP, Padmapriyadarsini C, Nancy A, et al
    Latent tuberculosis co-infection is associated with heightened levels of humoral, cytokine and acute phase responses in seropositive SARS-CoV-2 infection.
    J Infect. 2021 Jul 27. pii: S0163-4453(21)00372.
    >> Share

  41. TAN Y, Deng Y, Yan X, Liu F, et al
    Nontuberculous mycobacterial pulmonary disease and associated risk factors in China: A prospective surveillance study.
    J Infect. 2021;83:46-53.
    >> Share

  42. SONG Y, Dong Y, Liao Y, Liang Z, et al
    Apoptotic caspases suppress Mycobacterium bovis-induced IFN-beta production in murine macrophage.
    J Infect. 2021;83:61-68.
    >> Share

    May 2021
  43. DILLARD LK, Martinez RX, Perez LL, Fullerton AM, et al
    Prevalence of aminoglycoside-induced hearing loss in drug-resistant tuberculosis patients: A systematic review: Ototoxic hearing loss in drug-resistant tuberculosis.
    J Infect. 2021 May 17. pii: S0163-4453(21)00252.
    >> Share

  44. SAM IK, Chen YY, Ma J, Li SY, et al
    TB-QUICK: CRISPR-Cas12b-assisted rapid and sensitive detection of Mycobacterium tuberculosis.
    J Infect. 2021 May 2. pii: S0163-4453(21)00219.
    >> Share

    February 2021
  45. LIU Q, Fang X, Chen X, Dai X, et al
    Letter to the editor: Application of the Xpert MTB/RIF technology in the diagnosis and treatment of osteoarticular tuberculosis.
    J Infect. 2021 Feb 20. pii: S0163-4453(21)00092.
    >> Share

  46. WANG G, Jiang G, Jing W, Zong Z, et al
    Prevalence and molecular characterizations of seven additional drug resistance among multidrug-resistant tuberculosis in China: a subsequent study of a national survey.
    J Infect. 2021 Feb 5. pii: S0163-4453(21)00055.
    >> Share

  47. PATTERSON B, Abbara A, Collin S, Henderson M, et al
    Predicting drug-induced liver injury from anti-tuberculous medications by early monitoring of liver tests.
    J Infect. 2021;82:240-244.
    >> Share

    January 2021
  48. LOGAN C, Mullender C, Mirfenderesky M, Feasey N, et al
    Presentations and outcomes of central nervous system TB in a UK cohort: The high burden of neurological morbidity.
    J Infect. 2021;82:90-97.
    >> Share

  49. AHN CS, Shin JW, Kim JG, Lee WY, et al
    Spectrum of pleuropulmonary paragonimiasis: An analysis of 685 cases diagnosed over 22 years.
    J Infect. 2021;82:150-158.
    >> Share

  50. HEAD IM, Lazarus R
    Use of Xpert MTB/RIF in a low prevalence setting in the Southwest of England.
    J Infect. 2021;82:159-198.
    >> Share

    December 2020
  51. IZZARD A, Wilders S, Smith C, Wickers M, et al
    Improved treatment completion for Tuberculosis patients: the case for a dedicated social care team.
    J Infect. 2020 Dec 23. pii: S0163-4453(20)30780.
    >> Share

  52. MARINE E, Loic H, Christelle GC, Pierre-Louis N, et al
    Improving tuberculosis management in prisons: impact of a rapid molecular point-of-care test.
    J Infect. 2020 Dec 4. pii: S0163-4453(20)30764.
    >> Share

  53. ADANKWAH E, Nausch N, Minadzi D, Abass MK, et al
    Interleukin-6 and Mycobacterium tuberculosis dormancy antigens improve diagnosis of tuberculosis.
    J Infect. 2020 Dec 2. pii: S0163-4453(20)30729.
    >> Share

  54. LIU XH, Xia L, Song B, Wang H, et al
    Stool-based Xpert MTB/RIF Ultra Assay as a tool for detecting pulmonary tuberculosis in children with abnormal chest imaging: a prospective cohort study.
    J Infect. 2020 Dec 1. pii: S0163-4453(20)30727.
    >> Share

    November 2020
  55. VAN ZYL CW, Loots DT, Solomons R, van Reenen M, et al
    Metabolic characterization of tuberculous meningitis in a South African paediatric population using (1)H NMR metabolomics.
    J Infect. 2020;81:743-752.
    >> Share

    September 2020
  56. SUDBURY EL, Clifford V, Messina NL, Song R, et al
    Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review.
    J Infect. 2020 Sep 29. pii: S0163-4453(20)30631.
    >> Share

    August 2020
  57. CAPOCCI SJ, Sewell J, Smith C, Cropley I, et al
    Cost effectiveness of testing HIV infected individuals for TB in a low TB/HIV setting.
    J Infect. 2020;81:289-296.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016